Apologies Stezza, I meant to type FDA not TGA in my last sentence. Can't seem to edit it! Yes, I agree that TGA approval will give Colostat more credit with potential CLIA lab partners. Still, Colvera managed fine without it.
Possibly whatever deal is struck with a US company, there might be implications for the Australian market deals... so perhaps Rhythm themselves are holding off committing to anything there yet, until they know what is happening in Australia?
- Forums
- ASX - By Stock
- RHY
- Holiday Research - US competitive landscape and pan-cancer detection
Holiday Research - US competitive landscape and pan-cancer detection, page-12
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
Add RHY (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.68M |
Open | High | Low | Value | Volume |
4.7¢ | 4.8¢ | 4.2¢ | $9.183K | 197.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51425 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 68500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 51425 | 0.047 |
2 | 52542 | 0.043 |
1 | 47470 | 0.042 |
2 | 140586 | 0.041 |
2 | 524995 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 68500 | 1 |
0.056 | 20000 | 1 |
0.065 | 19644 | 2 |
0.066 | 79998 | 1 |
0.070 | 340394 | 2 |
Last trade - 14.17pm 02/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |